Abstract
The increase in serendipitous detection of solid renal masses on imaging has not resulted in a reduction in mortality from renal cell carcinoma. Consequently, efforts for improved lesion characterization have been pursued and incorporated into management algorithms for distinguishing clinically significant tumors from those with favorable histology or benign conditions. Although diagnostic imaging strategies have evolved for optimized lesion detection, distinction between benign tumors and both indolent and aggressive malignant neoplasms remain an important diagnostic challenge. Recent advances in cross-sectional imaging have expanded the role of these tests in the noninvasive characterization of solid renal tumors.
Original language | English (US) |
---|---|
Pages (from-to) | 311-330 |
Number of pages | 20 |
Journal | Urologic Clinics of North America |
Volume | 45 |
Issue number | 3 |
DOIs | |
State | Published - Aug 2018 |
Keywords
- Angiomyolipoma
- Image-guided biopsy
- Lymphoma
- MR imaging
- Renal cell carcinoma
- Renal oncocytoma
- Ultrasonography
- X-ray computed tomography
ASJC Scopus subject areas
- Urology